Clinical Therapeutics

Tolerability of short-term, high-dose formoterol in healthy volunteers and patients with asthma
pp. 2635-2646(12)
Author: Ostrom N.K.

The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist
pp. 2647-2668(22)
Authors: Davis K.L.; Nappi J.M.

Zoledronic acid: A new parenteral bisphosphonate
pp. 2669-2708(40)
Authors: Li E.C.; Davis L.E.

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction
pp. 2709-2723(15)
Authors: Govier F.; Potempa A.-J.; Kaufman J.; Denne J.; Kovalenko P.; Ahuja S.

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: Results of a European multicenter, open-label study of patient preference
pp. 2724-2737(14)
Authors: Stroberg P.; Murphy A.; Costigan T.

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d
pp. 2738-2753(16)
Authors: Davidson M.H.; Palmisano J.; Wilson H.; Liss C.; Dicklin M.R.

Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: A post hoc analysis
pp. 2754-2764(11)
Authors: Agrawal A.; Sautter M.C.; Jones N.P.

A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: The Val-Syst study
pp. 2765-2780(16)
Authors: Malacco E.; Vari N.; Capuano V.; Spagnuolo V.; Borgnino C.; Palatini P.; Val-Syst Investigators

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
pp. 2781-2796(16)
Authors: Schwartzberg L.; Shiffman R.; Tomita D.; Stolshek B.; Rossi G.; Adamson R.

Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study
pp. 2797-2808(12)
Authors: Hsieh M.-H.; Chan P.; Sue Y.-M.; Liu J.-C.; Liang T.H.; Huang T.-Y.; Tomlinson B.; Chow M.S.S.; Kao P.-F.; Chen Y.-J.

Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia
pp. 2809-2821(13)
Authors: Berger A.; Dukes E.; McCarberg B.; Liss M.; Oster G.

Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers
pp. 2822-2835(14)
Authors: Martin P.D.; Warwick M.J.; Dane A.L.; Hill S.J.; Giles P.B.; Phillips P.J.; Lenz E.

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus
pp. 2836-2848(13)
Authors: Korytkowski M.; Bell D.; Jacobsen C.; Suwannasari R.; FlexPenR Study Team

Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension
pp. 2849-2864(16)
Authors: Coca A.; Calvo C.; Sobrino J.; Lopez-Paz J.; Sierra C.; Gomez E.; Bragulat E.; de la Sierra A.

The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: A post hoc analysis of data from CHAMPS
pp. 2865-2874(10)
Author: O'Connor P.

Bioequivalence and other unresolved issues in generic drug substitution
pp. 2875-2890(16)
Author: Meredith P.

(Unlearned) lessons from John Graunt and Kenneth Rothman: A ''CLASSic'' example
pp. 2891-2896(6)
Authors: Arellano F.M.; Castellsague J.

Common sense isn't always (common)
pp. 2897-2897(1)
Author: Walson P.D.

Public-private partnerships at the national institutes of health: From discovery to commercialization
pp. 2900-2902(3)
Author: Lyles A.

Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine
pp. 2903-2919(17)
Authors: Williams P.; Reeder C.E.

Measuring satisfaction with migraine treatment: Expectations, importance, outcomes, and global ratings
pp. 2920-2935(16)
Authors: Patrick D.L.; Martin M.L.; Bushmell D.M.; Pesa J.

A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization
pp. 2936-2957(22)
Authors: Valuck R.J.; Williams S.A.; MacArthur M.; Saseen J.J.; Nair K.V.; McCollum M.; Endor J.E.

Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study
pp. 2958-2971(14)
Authors: Balkrishnan R.; Rajagopalan R.; Camacho F.T.; Huston S.A.; Murray F.T.; Anderson R.T.

Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer
pp. 2972-2987(16)
Authors: Simons W.R.; Jones D.; Buzdar A.